Isolating Circulating Cancer Stem Cells (CCSCs) from Human Whole Blood

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature..

Measuring circulating tumor cells (CTCs) or circulating cancer stem cells (CCSCs) in blood, which shed from primary tumors, is a noninvasive method to screen and/or diagnose patients with a high risk of developing metastatic cancers or relapse. Here, we describe an optimized and standardized laboratory method for isolating CCSCs from human blood samples, using cancer-specific stem cell biomarkers (Kantara et al., Lab Invest 95:100-112, 2015). When performing this technique, 0-1 circulating epithelial tumor cells/mL blood should be expected in patients free of malignant adenocarcinomas compared to over 3 circulating cancer stem cells/mL blood in patients positive for malignant adenocarcinomas (Kantara et al., Lab Invest 95:100-112, 2015).

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:2777

Enthalten in:

Methods in molecular biology (Clifton, N.J.) - 2777(2024) vom: 13., Seite 205-218

Sprache:

Englisch

Beteiligte Personen:

Kantara, Carla [VerfasserIn]
Singh, Pomila [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers
Biomarkers, Tumor
Buffy coat
Cancer stem cell biomarkers
Circulating cancer stem cells
Depletion
Human blood
Immunofluorescence
Journal Article
Red blood cells
Spheroids
White blood cells

Anmerkungen:

Date Completed 15.03.2024

Date Revised 15.03.2024

published: Print

Citation Status MEDLINE

doi:

10.1007/978-1-0716-3730-2_15

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369680588